Research ArticleArticle
Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance
Jessica A. Walsh, Shaobo Pei, Zachary Burningham, Gopi Penmetsa, Grant W. Cannon, Daniel O. Clegg and Brian C. Sauer
The Journal of Rheumatology November 2017, jrheum.170554; DOI: https://doi.org/10.3899/jrheum.170554
Jessica A. Walsh
From the Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Department of Internal Medicine, Divisions of Rheumatology and Epidemiology, Salt Lake City, Utah. Funding provided by the Marriott Daughters Foundation, the Rheumatology Research Foundation Scientist Development Award, the Ben B. and Iris M. Margolis Foundation, and the Spondyloarthritis Association of America. J.A. Walsh, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; S. Pei, MS, Salt Lake City Veterans Affairs Medical Center and University of Utah; Z. Burningham, PhD, Salt Lake City Veterans Affairs Medical Center; G. Penmetsa, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; G.W. Cannon, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; D.O. Clegg, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; B.C. Sauer, PhD, Salt Lake City Veterans Affairs Medical Center and University of Utah. Address correspondence to Dr. J.A. Walsh, Division of Rheumatology, School of Medicine, 30 North 1900 East, Salt Lake City, Utah 84132, USA. E-mail: jessica.walsh@hsc.utah.edu. Accepted for publication September 8, 2017.
Shaobo Pei
From the Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Department of Internal Medicine, Divisions of Rheumatology and Epidemiology, Salt Lake City, Utah. Funding provided by the Marriott Daughters Foundation, the Rheumatology Research Foundation Scientist Development Award, the Ben B. and Iris M. Margolis Foundation, and the Spondyloarthritis Association of America. J.A. Walsh, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; S. Pei, MS, Salt Lake City Veterans Affairs Medical Center and University of Utah; Z. Burningham, PhD, Salt Lake City Veterans Affairs Medical Center; G. Penmetsa, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; G.W. Cannon, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; D.O. Clegg, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; B.C. Sauer, PhD, Salt Lake City Veterans Affairs Medical Center and University of Utah. Address correspondence to Dr. J.A. Walsh, Division of Rheumatology, School of Medicine, 30 North 1900 East, Salt Lake City, Utah 84132, USA. E-mail: jessica.walsh@hsc.utah.edu. Accepted for publication September 8, 2017.
Zachary Burningham
From the Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Department of Internal Medicine, Divisions of Rheumatology and Epidemiology, Salt Lake City, Utah. Funding provided by the Marriott Daughters Foundation, the Rheumatology Research Foundation Scientist Development Award, the Ben B. and Iris M. Margolis Foundation, and the Spondyloarthritis Association of America. J.A. Walsh, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; S. Pei, MS, Salt Lake City Veterans Affairs Medical Center and University of Utah; Z. Burningham, PhD, Salt Lake City Veterans Affairs Medical Center; G. Penmetsa, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; G.W. Cannon, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; D.O. Clegg, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; B.C. Sauer, PhD, Salt Lake City Veterans Affairs Medical Center and University of Utah. Address correspondence to Dr. J.A. Walsh, Division of Rheumatology, School of Medicine, 30 North 1900 East, Salt Lake City, Utah 84132, USA. E-mail: jessica.walsh@hsc.utah.edu. Accepted for publication September 8, 2017.
Gopi Penmetsa
From the Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Department of Internal Medicine, Divisions of Rheumatology and Epidemiology, Salt Lake City, Utah. Funding provided by the Marriott Daughters Foundation, the Rheumatology Research Foundation Scientist Development Award, the Ben B. and Iris M. Margolis Foundation, and the Spondyloarthritis Association of America. J.A. Walsh, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; S. Pei, MS, Salt Lake City Veterans Affairs Medical Center and University of Utah; Z. Burningham, PhD, Salt Lake City Veterans Affairs Medical Center; G. Penmetsa, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; G.W. Cannon, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; D.O. Clegg, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; B.C. Sauer, PhD, Salt Lake City Veterans Affairs Medical Center and University of Utah. Address correspondence to Dr. J.A. Walsh, Division of Rheumatology, School of Medicine, 30 North 1900 East, Salt Lake City, Utah 84132, USA. E-mail: jessica.walsh@hsc.utah.edu. Accepted for publication September 8, 2017.
Grant W. Cannon
From the Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Department of Internal Medicine, Divisions of Rheumatology and Epidemiology, Salt Lake City, Utah. Funding provided by the Marriott Daughters Foundation, the Rheumatology Research Foundation Scientist Development Award, the Ben B. and Iris M. Margolis Foundation, and the Spondyloarthritis Association of America. J.A. Walsh, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; S. Pei, MS, Salt Lake City Veterans Affairs Medical Center and University of Utah; Z. Burningham, PhD, Salt Lake City Veterans Affairs Medical Center; G. Penmetsa, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; G.W. Cannon, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; D.O. Clegg, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; B.C. Sauer, PhD, Salt Lake City Veterans Affairs Medical Center and University of Utah. Address correspondence to Dr. J.A. Walsh, Division of Rheumatology, School of Medicine, 30 North 1900 East, Salt Lake City, Utah 84132, USA. E-mail: jessica.walsh@hsc.utah.edu. Accepted for publication September 8, 2017.
Daniel O. Clegg
From the Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Department of Internal Medicine, Divisions of Rheumatology and Epidemiology, Salt Lake City, Utah. Funding provided by the Marriott Daughters Foundation, the Rheumatology Research Foundation Scientist Development Award, the Ben B. and Iris M. Margolis Foundation, and the Spondyloarthritis Association of America. J.A. Walsh, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; S. Pei, MS, Salt Lake City Veterans Affairs Medical Center and University of Utah; Z. Burningham, PhD, Salt Lake City Veterans Affairs Medical Center; G. Penmetsa, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; G.W. Cannon, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; D.O. Clegg, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; B.C. Sauer, PhD, Salt Lake City Veterans Affairs Medical Center and University of Utah. Address correspondence to Dr. J.A. Walsh, Division of Rheumatology, School of Medicine, 30 North 1900 East, Salt Lake City, Utah 84132, USA. E-mail: jessica.walsh@hsc.utah.edu. Accepted for publication September 8, 2017.
Brian C. Sauer
From the Salt Lake City Veterans Affairs Medical Center and University of Utah School of Medicine, Department of Internal Medicine, Divisions of Rheumatology and Epidemiology, Salt Lake City, Utah. Funding provided by the Marriott Daughters Foundation, the Rheumatology Research Foundation Scientist Development Award, the Ben B. and Iris M. Margolis Foundation, and the Spondyloarthritis Association of America. J.A. Walsh, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; S. Pei, MS, Salt Lake City Veterans Affairs Medical Center and University of Utah; Z. Burningham, PhD, Salt Lake City Veterans Affairs Medical Center; G. Penmetsa, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; G.W. Cannon, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; D.O. Clegg, MD, Salt Lake City Veterans Affairs Medical Center and University of Utah; B.C. Sauer, PhD, Salt Lake City Veterans Affairs Medical Center and University of Utah. Address correspondence to Dr. J.A. Walsh, Division of Rheumatology, School of Medicine, 30 North 1900 East, Salt Lake City, Utah 84132, USA. E-mail: jessica.walsh@hsc.utah.edu. Accepted for publication September 8, 2017.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance
Jessica A. Walsh, Shaobo Pei, Zachary Burningham, Gopi Penmetsa, Grant W. Cannon, Daniel O. Clegg, Brian C. Sauer
The Journal of Rheumatology Nov 2017, jrheum.170554; DOI: 10.3899/jrheum.170554
Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance
Jessica A. Walsh, Shaobo Pei, Zachary Burningham, Gopi Penmetsa, Grant W. Cannon, Daniel O. Clegg, Brian C. Sauer
The Journal of Rheumatology Nov 2017, jrheum.170554; DOI: 10.3899/jrheum.170554